Selective phosphodiesterase type 4 inhibitors reduce the prolonged survival of eosinophils stimulated by granulocyte-macrophage colony-stimulating factor

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 2, 2002, Pages 184-187

  Takeuchi, Masayuki ^a   Tatsumi, Yasuaki ^b   Kitaichi, Kiyoyuki ^b   Baba, Kenji ^c   Suzuki, Ryujiro ^a   Shibata, Eiji ^b   Takagi, Kenji ^b   Miyamoto, Ken Ichi ^d   Hasegawa, Takaaki ^b   Takagi, Kenzo ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Bronchial asthma; Eosinophil survival; Granulocyte macrophage colony stimulating factor; Phosphodiesterase inhibitor; Rolipram; XT 611

Indexed keywords

3,4 DIPROPYL 4,5,7,8 TETRAHYDRO 3H IMIDAZO[1,2 I]PURIN 5 ONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM; THEOPHYLLINE; TRYPAN BLUE; UNCLASSIFIED DRUG; XT 611; 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 3,4 DIPROPYL 4,5,7,8 TETRAHYDRO 3H IMIDAZO(1,2 I)PURIN 5 ONE; 3,4-DIPROPYL-4,5,7,8-TETRAHYDRO-3H-IMIDAZO(1,2-I)PURIN-5-ONE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PURINE DERIVATIVE;

ARTICLE; ASTHMA; CELL ISOLATION; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SCREENING; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; MALE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; CELL SURVIVAL; CELLS, CULTURED; EOSINOPHILS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; PURINES; ROLIPRAM; THEOPHYLLINE;

EID: 9944259452     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.184     Document Type: Article

References (28)

1. Barnes P. J., J. Internal Med., 231, 453-461 (1992).
2. Owen W. F., Rothenberg M. E., Silberstein D. S., Gasson J. C., Stevens R, L., Austen K. F., Sobermann R. J., J. Exp. Med., 166, 129-141 (1987).
3. Rothenberg M. E., Owen W. F., Silberstein D. S., Woods J., Sobermann R. J., Austen K. F., Stevens R. L., J. Clin. Invest., 81, 1986-1992 (1988).
4. Rothenberg M. E., Peterson J., Stevens R. L., Silberstein D. S., McKenzie D. T., Austen K. F., Owen W. F., J. Immunol., 143, 2311-2316 (1989).
5. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takaku K., J. Exp. Med., 167, 1737-1742 (1988).
6. Yamaguchi Y., Suda T., Ohta S., Tominaga K., Miura Y., Kasahara T., Blood, 78, 2542-2547 (1991).
7. Soloperto M., Mattoso V. L., Fasoli A., Mattoli S., Am. J. Physiol., 260, L530-L538 (1991).
8. Broide D. H., Paine M. M., Firestein G. S., J. Clin. Invest., 90, 1414-1424 (1992).
9. Hallsworth M. P., Giembycz M. A., Barnes P. J., Lee T. H., Br. J. Pharmacol., 117, 79-86 (1996).
10. Kidney J., Dominguez M., Taylor P. M., Rose M., Chung K. F., Barnes P. J., Am. J. Respir. Crit. Care Med., 151, 1907-1914 (1995).
11. Ohta K., Sawamoto S., Nakajima M., Kubota S., Tanaka Y., Miyasaka T., Nagai A., Hirai K., Mano K., Miyashita H., Clin. Exp. Allergy, 26 (Suppl. 2), 10-15 (1996).
12. Nicholson C. D., Challiss R. A. J., Shahid M., Trends Pharmacol. Sci., 12, 19-27 (1991).
13. Shahid M., van Amsterdam R. G. M., de Boer J., ten Berger R. E., Nicholson C. D., Zaagsma J., Br. J. Pharmacol., 104, 471-477 (1991).
14. Hughes B., Owens R., Perry M., Warrellow G., Allen R., Drug Discovery Today, 2, 89-101 (1997).
15. Teixeira M. M., Gristwood R. W., Cooper N., Hellwell P. G., Trends Pharmacol. Sci., 18, 164-171 (1997).
16. Sawanishi H., Suzuki H., Yamamoto S., Waki Y., Kasugai S., Ohya K., Suzuki N., Miyamoto K., Takagi K., J. Med. Chem., 40, 3248-3253 (1997).
17. Pintro I. L., Buckle D. R., Readshaw S. A., Smith D. G., Bioorg. Med. Chem. Lett., 13, 1743-1746 (1993).
18. Hansel T. T., De Vries I. J. M., Iff M. T., Rihs S., Wandzilak M., Betz S., Walker C. J., Immunol. Methods, 145, 105-110 (1991).
19. Kretowski A., Mysliwiec J., Kinalska I., Scand. J. Immunol., 51, 321-325 (2000).
20. Spry C. J. F., "Immunopharmacology of Eosinophils," ed. by Smith H., Cook R. M., Academic Press, London, 1993. pp. 1-9.
21. Walsh G. M., Clin. Exp. Allergy, 27, 482-487 (1997).
22. Beasley R., Roche W. R., Roberts J. A., Holgate S. T., Am. Rev. Respir. Dis., 139, 806-817 (1989).
23. Zhang S., Mohammed Q., Burbidge A., Morland C. M., Roche W. R., Eur. Respir. J., 9, 1839-1846 (1996).
24. Beavo J. A., Reifsynder D. H., Trends Pharmacol. Sci., 11, 150-155 (1990).
25. Nicholson C. D., Shahid M., Pulm, Pharmacol., 7, 1-17 (1994); Giembycz M. A., Biochem. Pharmacol., 43, 2041-2051 (1992).
26. Nicholson C. D., Shahid M., Pulm, Pharmacol., 7, 1-17 (1994); Giembycz M. A., Biochem. Pharmacol., 43, 2041-2051 (1992).
27. Yasui K., Bin H., Nakazawa T., Agematsu K., Kamiyama A., J. Clin. Invest., 100, 1677-1684 (1997).
28. Takeuchi M., Hayakawa A., Takagi K., Hiramatsu K., Shimizu Y., Matsumoto S., Hiramatsu T., Ito, Y., Kume H., Suzuki R., Yamaki K., Apoptosis, 4, 461-468 (1999).